NASDAQ:CAMP • US13463J1016
Past quarterly earnings results for CAMP4 THERAPEUTICS CORP (CAMP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.55 | -0.49 | -12.73% | 97.73% | 795K | 530.4K | 49.89% | - |
| Q2 2025 | -0.62 | -0.69 | 9.55% | -169.57% | 1.497M | 612K | 144.61% | -97.57% |
| Q1 2025 | -0.62 | -0.71 | 13.17% | -369.57% | 858K | 25.5K | 3,264.71% | -98.79% |
| Q4 2024 | -2.83 | -0.84 | -237.33% | -305.07% | 652K | 147.9K | 340.84% | -99.17% |
| Q3 2024 | -24.19 | -1.09 | -2,111.25% | - | 339.997K | -100.00% | -100.00% | |
| Q2 2024 | -0.23 | 0.70 | -132.68% | -1,050.00% | 61.714M | 71.758M | -14.00% | -15.26% |
| Q1 2024 | 0.23 | 0.94 | -75.49% | 330.00% | 70.891M | 77.173M | -8.14% | 9.52% |
| Q4 2023 | 1.38 | 0.38 | 263.11% | 13,900.00% | 78.506M | 80.22M | -2.14% | 14.81% |
| Q3 2023 | 0.00 | 0.00 | -100.00% | 100.00% | 78.889M | 76.799M | 2.72% | 14.70% |
| Q2 2023 | -0.02 | -0.03 | 30.79% | -125.00% | 72.828M | 70.658M | 3.07% | -7.83% |
| Q1 2023 | -0.10 | -0.03 | -209.56% | -225.00% | 64.726M | 70.818M | -8.60% | -18.76% |
| Q4 2022 | -0.01 | -0.08 | 87.35% | -107.14% | 68.377M | 69.801M | -2.04% | 20.33% |
| Q3 2022 | -0.08 | 0.08 | -194.50% | -214.29% | 68.777M | 80.763M | -14.84% | -12.40% |
| Q2 2022 | 0.08 | 0.06 | 27.18% | 366.67% | 79.011M | 81.509M | -3.06% | 6.20% |
| Q1 2022 | 0.08 | 0.07 | 12.04% | 300.00% | 79.674M | 81.859M | -2.67% | 8.06% |
| Q4 2021 | 0.14 | 0.06 | 152.82% | 366.67% | 56.823M | 85.352M | -33.43% | 32.55% |
| Q3 2021 | 0.07 | 0.02 | 220.24% | -53.33% | 78.512M | 84.635M | -7.23% | -18.72% |
| Q2 2021 | -0.03 | 0.00 | -1,956.77% | -121.43% | 74.397M | 78.379M | -5.08% | -20.21% |
| Q1 2021 | 0.02 | -0.06 | 136.12% | -83.33% | 73.731M | 76.8M | -4.00% | -17.22% |
| Q4 2020 | 0.03 | 0.03 | 18.31% | - | 42.87M | 87.66M | -51.10% | - |
| Q3 2020 | 0.15 | 0.15 | -1.23% | - | 96.597M | 97.014M | -0.43% | - |
| Q2 2020 | 0.14 | 0.12 | 19.01% | - | 93.236M | 93.385M | -0.16% | - |
| Q1 2020 | 0.12 | 0.09 | 34.02% | - | 89.07M | 88.646M | 0.48% | - |
Notes
CAMP4 THERAPEUTICS CORP (CAMP) last reported earnings on 11/6/2025.
CAMP4 THERAPEUTICS CORP (CAMP) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, CAMP4 THERAPEUTICS CORP (CAMP) has beaten EPS estimates in 2 out of 4 releases.